In-Depth Review on Lithotech Medical Ltd. - Product Pipeline Analysis, 2016 Update
Lithotech Medical Ltd. - Product Pipeline Analysis, 2016 Update is a new market research publication announced by Reportstack. Lithotech Medical Ltd. (Lithotech Medical) is a medical device manufacturing company that designs and develops invasive medical devices based on nickel titanium alloy wires and nano-pulse technology. The company also manufactures extractors, graspers and baskets. It also offers NiTi Wiring nitinol retrieval and entrapping device; and Lithotripter urinary tract stone shuttering and crushing device. Lithotech Medical produces various product lines in different configurations and sizes. The company operates with development of medical devices for cardiovascular, urology and gastro fields. It includes research and development facilities in northern Israel and Tomsk, Russia. Lithotech Medical is headquartered in Tel Aviv, Israel.
To access full report with TOC, please visit Lithotech Medical Ltd. - Product Pipeline Analysis, 2016 Update
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Companies Mentioned
STI Laser Industries Ltd. Earlysense Ltd Direx Systems Corp. Cook Urological Incorporated Boston Scientific Asia Pacific Pte Ltd Apexum Ltd. Alma Lasers, Ltd.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###
posted by Reportstack @ 22:44
0 Comments
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home